In this experiment, we demonstrated no difference in CD7 expression between the normal cell population of R/R-AML patients and healthy donors (HDs), whereas 31.25% (5/16) of R/R-AML patients exhibited varying degrees of CD7 expression. This evidence concerns the gene CD7 and acute myeloid leukemia.